Literature DB >> 2497176

Molecular study of the T cell repertoire in family contacts and patients with leprosy.

P Mendez-Samperio1, J Lamb, G Bothamley, P Stanley, C Ellis, J Ivanyi.   

Abstract

The specificity of lymphocyte proliferative responses of 22 family contacts and 7 patients with leprosy were analyzed using Ag fractions from soluble extracts of Mycobacterium leprae and Mycobacterium tuberculosis. Fractions 10-100 kDa m.w. from each extract were separated by SDS-polyacrylamide gel electrophoresis, electroblotted to nitrocellulose membrane and solubilized for use in lymphocyte culture. The main immunogenic fractions for both contacts and patients had m.w. of 12,000 to 22,000, 35,000 to 40,000, and 65,000. Determinants which were either distinct or shared by the two extracts were active in each of the immunogenic fractions. Lymphocyte proliferation following stimulation with separated Ag was found also in five subjects who failed to respond to the whole soluble extracts. Stimulatory synthetic peptides were identified for the 65 kDa protein Ag. This technique has permitted the screening of the T cell immune repertoire for the identification of the immunodominant Ag which merit further purification and molecular characterization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497176

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

Authors:  A Tärnvik; M Eriksson; G Sandström; A Sjöstedt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one- and two-dimensional cellular immunoblotting.

Authors:  B M Brooks-Worrell; G A Splitter
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Lack of cytotoxic activity against Mycobacterium leprae 65-kD heat shock protein (hsp) in multibacillary leprosy patients.

Authors:  S de la Barrera; S Fink; M Finiasz; F Minnucci; R Valdez; L M Baliña; M C Sasiain
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

4.  Sodium dodecyl sulfate- and salt-extracted antigens from various Brucella species induce proliferation of bovine lymphocytes.

Authors:  B M Brooks-Worrell; G A Splitter
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Human cell-mediated immune responses to antigenic fractions of Salmonella typhi.

Authors:  C Pérez; G M Calderón; C Ximénez; E I Melendro
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

6.  T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.

Authors:  P Launois; K Huygen; J De Bruyn; M N'Diaye; B Diouf; L Sarthouj; J Grimaud; J Millan
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

7.  Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads.

Authors:  R H Gelber; V Mehra; B Bloom; L P Murray; P Siu; M Tsang; P J Brennan
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

8.  T cell proliferative responses to molecular fractions of periodontopathic bacteria.

Authors:  L Ivanyi; H N Newman; P D Marsh
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

9.  T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts.

Authors:  B Chua-Intra; S Peerapakorn; N Davey; S Jurcevic; M Busson; H M Vordermeier; C Pirayavaraporn; J Ivanyi
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts.

Authors:  M Torres; P Mendez-Sampeiro; L Jimenez-Zamudio; L Teran; A Camarena; R Quezada; E Ramos; E Sada
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.